Approaches to modernize the combination drug development paradigm


Recent advances in genomic sequencing and omics-based capabilities are uncovering tremendous therapeutic opportunities and rapidly transforming the field of cancer medicine. Molecularly targeted agents aim to exploit key tumor-specific vulnerabilities such as oncogenic or non-oncogenic addiction and synthetic lethality. Additionally, immunotherapies… (More)
DOI: 10.1186/s13073-016-0369-x


6 Figures and Tables

Cite this paper

@inproceedings{Day2016ApproachesTM, title={Approaches to modernize the combination drug development paradigm}, author={Daphne Day and Lillian L. Siu}, booktitle={Genome Medicine}, year={2016} }